Triple-negative breast cancer (TNBC) assigns to a subgroup of breast cancer (BC) determined by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.